Does LENALIDOMIDE Cause Hepatic cancer? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Hepatic cancer have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.
70
Reports of Hepatic cancer with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
23
Deaths
22
Hospitalizations
How Dangerous Is Hepatic cancer From LENALIDOMIDE?
Of the 70 reports, 23 (32.9%) resulted in death, 22 (31.4%) required hospitalization, and 3 (4.3%) were considered life-threatening.
Is Hepatic cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Hepatic cancer?
RANITIDINE (17,818)
SORAFENIB (228)
LEDIPASVIR\SOFOSBUVIR (197)
ADALIMUMAB (193)
RIBAVIRIN (190)
VALSARTAN (165)
RIFAXIMIN (151)
SOFOSBUVIR (141)
ETANERCEPT (97)
ENTECAVIR (94)
Which LENALIDOMIDE Alternatives Have Lower Hepatic cancer Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE